Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mahr

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Clinical Chemistry|November 1, 1988
Use of creatine kinase MB isoenzyme for diagnosing myocardial infarction when total creatine kinase activity is highW G Thompson, R G Mahr, W S Yohannan, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitroU Fuhr, E M Anders, G Mahr, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1997
Analysis of metabolites--a new approach to bioequivalence studies of spironolactone formulationsH Vergin, G Mahr, R Metz, et al.
Clinical Pharmacokinetics|January 1, 1992
Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokineticsF Sörgel, G Mahr, G R Granneman, et al.
Clinical Pharmacokinetics|January 1, 1992
Hepatobiliary elimination of temafloxacinF Sörgel, G R Granneman, G Mahr, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1993
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meningesR Nau, H W Prange, P Muth, et al.
Clinical Pharmacokinetics|January 1, 1992
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeineG Mahr, F Sörgel, G R Granneman, et al.
Journal of Behavioral Medicine|October 20, 2000
Chest pain and the treatment of psychosocial/emotional distress in CAD patientsM W Ketterer, F Fitzgerald, S Keteyian, et al.
Clinical Pharmacokinetics|January 1, 1992
Pharmacokinetics of temafloxacin in patients with liver impairmentG R Granneman, G Mahr, C Locke, et al.
Journal of Cardiovascular Risk|January 13, 2001
Psychosocial and traditional risk factors in early ischaemic heart disease: cross-sectional correlatesM W Ketterer, F Fitzgerald, B Thayer, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical Chemistry|November 1, 1988
Use of creatine kinase MB isoenzyme for diagnosing myocardial infarction when total creatine kinase activity is highW G Thompson, R G Mahr, W S Yohannan, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitroU Fuhr, E M Anders, G Mahr, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1997
Analysis of metabolites--a new approach to bioequivalence studies of spironolactone formulationsH Vergin, G Mahr, R Metz, et al.
Clinical Pharmacokinetics|January 1, 1992
Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokineticsF Sörgel, G Mahr, G R Granneman, et al.
Clinical Pharmacokinetics|January 1, 1992
Hepatobiliary elimination of temafloxacinF Sörgel, G R Granneman, G Mahr, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1993
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meningesR Nau, H W Prange, P Muth, et al.
Clinical Pharmacokinetics|January 1, 1992
Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeineG Mahr, F Sörgel, G R Granneman, et al.
Journal of Behavioral Medicine|October 20, 2000
Chest pain and the treatment of psychosocial/emotional distress in CAD patientsM W Ketterer, F Fitzgerald, S Keteyian, et al.
Clinical Pharmacokinetics|January 1, 1992
Pharmacokinetics of temafloxacin in patients with liver impairmentG R Granneman, G Mahr, C Locke, et al.
Journal of Cardiovascular Risk|January 13, 2001
Psychosocial and traditional risk factors in early ischaemic heart disease: cross-sectional correlatesM W Ketterer, F Fitzgerald, B Thayer, et al.
Pageof 4